Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Journal of Experimental Therapeutics & Oncology|May 3, 2003
Phosphatidylcholine-derived phosphatidic acid and diacylglycerol are involved in the signaling pathways activated by docetaxelNicolas Maestre, Christine Bezombes, Isabelle Plo, et al.Blood|August 17, 2006
Syk-dependent mTOR activation in follicular lymphoma cellsLudivine Leseux, Safouane M Hamdi, Talal Al Saati, et al.The Biochemical Journal|March 10, 2007
PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide productionAlexandra Charruyer, Christine Jean, Audrey Colomba, et al.Molecular Pharmacology|November 19, 2002
Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activationChristine Bezombes, Aurélie de Thonel, Andriana Apostolou, et al.Cellular & Molecular Immunology|December 18, 2012
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?Jean-Jacques Fournié, Hélène Sicard, Mary Poupot, et al.Blood|May 6, 2004
Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomainsChristine Bezombes, Solène Grazide, Céline Garret, et al.European Journal of Immunology|July 26, 2017
IL-33-expanded human Vγ9Vδ2 T cells have anti-lymphoma effect in a mouse tumor modelCaroline Duault, Delphine Betous, Christine Bezombes, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2002
Ara-C- and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane raftsSolène Grazide, Nicolas Maestre, Robert Jan Veldman, et al.Blood|December 8, 2009
Rituximab inhibits B-cell receptor signalingSamar Kheirallah, Pierre Caron, Emilie Gross, et al.Oncotarget|April 14, 2017
Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studiesPauline Gravelle, Barbara Burroni, Sarah Péricart, et al.Pageof 4